Less is More


Nicholas Kaiser of Saturna Capital describes what “quant” investing taught him about fundamental research, why he’s so comfortable investing in cyclicals, the country with which he’s particularly enamored as an investor, how he combats excessive skepticism, and why he sees mispriced value in Intel, UnitedHealth, Devon Energy and Emcor.

If you are a subscriber, log in to access the issue and bonus archive: